市場調査レポート

商品コード

1355024

抗菌剤の世界市場の評価：グレード別、タイプ別、用途別、エンドユーザー別、地域別、機会、予測（2016年～2030年）

Antimicrobials Market Assessment, By Grade, By Type, By Applications, By End-user, By Region, Opportunities and Forecast, 2016-2030F

出版日: 2023年10月03日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 134 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 707,130円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 895,698円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,288,548円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の抗菌剤の市場規模は、2022年の418億2,000万米ドルから2030年に604億米ドルに達し、2023年～2030年の予測期間にCAGRで4.7%の成長が予測されています。

生活必需品への広範な用途が市場の成長を後押し

世界のホームケア製品の市場規模は、2022年の1兆956億3,000万米ドルから2023年に1兆1,553億6,000万米ドルへと大きく成長し、驚異的な成長部門として認識されています。持続可能で効果的なホームケア製品を開発するための技術革新への頻繁な投資が、抗菌性化合物にとって申し分のない機会を生み出しています。また、建設産業における抗菌剤の膨大な利用により、不動産の増加とともに市場が飛躍的に成長する機会があります。

抗がん剤として組み込まれた抗菌ペプチドが医療部門に革命を起こす

米国のNational Center for Health Statisticsによると、米国では2022年に約191万8,030人のがん患者が診断され、男性のがん患者のほうが多く98万3,160人でした。Iqviaが発表したデータによると、2022年の世界のがん治療薬への投資は1,960億米ドルで、今後飛躍的に増加すると推定されています。がん治療における医薬品革新の巨大な可能性は、世界中で抗菌ペプチドの巨大な機会を信じられないほど生み出しています。

COVID-19の影響

COVID-19の発生は、全人類がこの感染症に弱いという前代未聞の衝撃を与えました。重要な抗生物質が入手できないため、抗菌剤耐性は治療不可能な細菌感染症の治療において医療システム全体を次々と脅かしてきました。経験的な抗菌剤の処方や抗菌性衛生用品の過剰な消費など、いくつかの従来の習慣は、抗菌剤耐性の蔓延に悪影響を及ぼしました。パンデミックは、抗菌剤やワクチンの研究開発における持続可能な資金調達の橋渡しをすることになりました。このような課題に対処するため、WHOとそのパートナーであるDrugs for Neglected Diseases initiative（DNDi）は、革新的で新規な治療法を開発するためGlobal Antibiotic R&D Partnership（GARDP）を設立しました。COVID-19パンデミックの間、抗菌剤の世界市場は効果的に成長し、より多くの企業が抗菌剤耐性の問題に取り組むようになっています。

ロシア・ウクライナ戦争の影響

ロシアのウクライナへの侵攻は、経済的だけでなく物理的な荒廃をもたらし、さまざまな部門に影響を及ぼし、投資の不安定化につながっています。ロシアの侵略はウクライナの医療システムに深刻な影響を与え、負傷した兵士の間で細菌感染が大きく増加しました。欧米諸国からの医療援助により、ウクライナの現状はある程度安定しており、こうした国々は戦争によるウクライナの生活への影響と闘うために努力を続けています。

当レポートでは、世界の抗菌剤市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

市場規模と予測
- 金額
- 数量
グレード別
- 食品グレード
- 製薬グレード
- 工業グレード
タイプ別
- 有機
- 無機
用途別
- 抗ウイルス保護
- 食品包装
- 細菌の増殖の阻害
- その他
エンドユーザー別
- ホームケアの必需品
- 農業
- 洗剤
- 紙・パルプ
- インク・接着剤
- 医薬品
- パーソナルケア
- その他
地域別
- 北米
- 欧州
- 南米
- アジア太平洋
- 中東・アフリカ
市場シェア：企業別（2022年）

第8章世界の抗菌剤市場の見通し：地域別（2016年～2030年）

北米
- 市場規模と予測
- グレード別
- タイプ別
- 用途別
- エンドユーザー別
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- イタリア
- 英国
- ロシア
- オランダ
- スペイン
- トルコ
- ポーランド
南米
- ブラジル
- アルゼンチン
アジア太平洋
- インド
- 中国
- 日本
- オーストラリア
- ベトナム
- 韓国
- インドネシア
- フィリピン
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- 南アフリカ

第9章サプライサイド分析

生産能力：企業別
生産：企業別
営業効率：企業別
主な工場の所在地（最大25）

第10章市場マッピング（2022年）

グレード別
タイプ別
用途別
エンドユーザー別
地域別

第11章マクロ環境と産業構造

需給分析
輸出入の分析 - 数量と金額
サプライ/バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第12章市場力学

成長促進要因
成長抑制要因（課題、抑制要因）

第13章主要企業情勢

マーケットリーダー上位5社の競合マトリクス
マーケットリーダー上位5社市場の収益分析（2022年）
合併と買収/合弁事業（該当する場合）
SWOT分析（市場参入企業5社向け）
特許分析（該当する場合）

第14章価格分析

第15章ケーススタディ

第16章主要企業の見通し

Iasis Molecular Science
EnBiotix Inc.
Armata Pharmaceuticals
GlaxoSmithKline
Fresenius Kabi Global
Destiny Pharma
Phico Therapeutics
SaNOtize
BioVersys
Pylum Biosciences

第17章戦略的推奨事項

第18章当社について、免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 2. Global Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 3. Global Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 4. Global Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 5. Global Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 6. Global Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 7. Global Antimicrobials Market Share, By Region, In USD Billion, 2016-2030F
Figure 8. North America Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 9. North America Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 10. North America Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 11. North America Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 12. North America Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 13. North America Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 14. North America Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
Figure 15. United States Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 16. United States Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 17. United States Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 18. United States Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 19. United States Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 20. United States Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 21. Canada Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 22. Canada Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 23. Canada Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 24. Canada Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 25. Canada Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 26. Canada Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 27. Mexico Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 28. Mexico Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 29. Mexico Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 30. Mexico Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 31. Mexico Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 32. Mexico Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 33. Europe Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 34. Europe Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 35. Europe Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 36. Europe Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 37. Europe Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 38. Europe Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 39. Europe Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
Figure 40. Germany Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 41. Germany Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 42. Germany Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 43. Germany Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 44. Germany Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 45. Germany Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 46. France Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 47. France Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 48. France Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 49. France Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 50. France Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 51. France Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 52. Italy Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 53. Italy Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 54. Italy Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 55. Italy Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 56. Italy Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 57. Italy Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 58. United Kingdom Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 59. United Kingdom Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 60. United Kingdom Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 61. United Kingdom Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 62. United Kingdom Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 63. United Kingdom Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 64. Russia Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 65. Russia Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 66. Russia Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 67. Russia Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 68. Russia Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 69. Russia Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 70. Netherlands Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 71. Netherlands Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 72. Netherlands Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 73. Netherlands Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 74. Netherlands Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 75. Netherlands Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 76. Spain Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 77. Spain Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 78. Spain Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 79. Spain Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 80. Spain Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 81. Spain Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 82. Turkey Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 83. Turkey Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 84. Turkey Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 85. Turkey Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 86. Turkey Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 87. Turkey Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 88. Poland Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 89. Poland Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 90. Poland Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 91. Poland Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 92. Poland Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 93. Poland Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 94. South America Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 95. South America Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 96. South America Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 97. South America Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 98. South America Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 99. South America Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 100. South America Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
Figure 101. Brazil Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 102. Brazil Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 103. Brazil Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 104. Brazil Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 105. Brazil Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 106. Brazil Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 107. Argentina Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 108. Argentina Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 109. Argentina Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 110. Argentina Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 111. Argentina Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 112. Argentina Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 113. Asia-Pacific Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 114. Asia-Pacific Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 115. Asia-Pacific Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 116. Asia-Pacific Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 117. Asia-Pacific Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 118. Asia- Pacific Cream Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 119. Asia-Pacific Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
Figure 120. India Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 121. India Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 122. India Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 123. India Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 124. India Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 125. India Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 126. China Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 127. China Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 128. China Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 129. China Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 130. China Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 131. China Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 132. Japan Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 133. Japan Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 134. Japan Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 135. Japan Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 136. Japan Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 137. Japan Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 138. Australia Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 139. Australia Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 140. Australia Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 141. Australia Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 142. Australia Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 143. Australia Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 144. Vietnam Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 145. Vietnam Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 146. Vietnam Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 147. Vietnam Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 148. Vietnam Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 149. Vietnam Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 150. South Korea Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 151. South Korea Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 152. South Korea Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 153. South Korea Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 154. South Korea Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 155. South Korea Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 156. Indonesia Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 157. Indonesia Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 158. Indonesia Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 159. Indonesia Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 160. Indonesia Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 161. Indonesia Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 162. Philippines Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 163. Philippines Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 164. Philippines Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 165. Philippines Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 166. Philippines Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 167. Philippines Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 168. Middle East & Africa Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 169. Middle East & Africa Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 170. Middle East & Africa Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 171. Middle East & Africa Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 172. Middle East & Africa Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 173. Middle East & Africa Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 174. Middle East & Africa Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
Figure 175. Saudi Arabia Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 176. Saudi Arabia Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 177. Saudi Arabia Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 178. Saudi Arabia Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 179. Saudi Arabia Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 180. Saudi Arabia Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 181. UAE Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 182. UAE Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 183. UAE Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 184. UAE Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 185. UAE Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 186. UAE Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 187. South Africa Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 188. South Africa Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 189. South Africa Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 190. South Africa Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 191. South Africa Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 192. South Africa Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 193. By Grade Map-Market Size (USD Billion) & Growth Rate (%), 2022
Figure 194. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2022
Figure 195. By Applications Map-Market Size (USD Billion) & Growth Rate (%), 2022
Figure 196. By End-user Industry Map-Market Size (USD Billion) & Growth Rate (%), 2022
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2022

Product Code: MX10476

Global antimicrobials market size was valued at USD 41.82 billion in 2022, expected to reach USD 60.4 billion in 2030, with a CAGR of 4.7% for the forecast period between 2023 and 2030. The discovery of antimicrobials has benefited various sectors progressively with the adopted innovations. The incorporated antimicrobials deliver specific characteristics based on the group they belong to. Specific mechanisms, such as inhibiting protein, cell wall, and nuclei acid synthesis, depolarize the cell membrane and inhibit metabolic pathways in bacteria. Antimicrobial peptides have the potential to impart either antimicrobial or anticancer activities that subsequently disrupt microbial cell membranes by making proper interaction with negatively charged phospholipids. Antimicrobials have extensive involvement in the agri-food sector, which is responsible for imprudent use, and their prominent contribution to resistance can diminish the concerns for health emergencies.

Extensive Application in Daily Essentials Augments Market Growth

Several prominent factors of antimicrobial compounds are responsible for their numerous applications in balancing hygienic-critical environments. Incorporating antimicrobial compounds assists in enhancing the cleanliness and freshness of everyday products by restricting the proliferation of unpleasant mold and mildew. Its essential characteristic is preserving plastic products by inhibiting physical degradation from fungi and bacteria. By minimizing stain and odor-causing bacteria, antimicrobial compounds remain potentially active in imparting laundering properties in fabric care products.

The global home care product market has grown significantly from USD 1,095.63 billion in 2022 to USD 1,155.36 billion in 2023, recognized as a phenomenal rising sector. The frequent investment in innovations to develop sustainable and effective home care products has created impeccable opportunities for antimicrobial compounds. Also, with the huge application of antimicrobials in the construction industry, it has market opportunities to grow exponentially with the rise in real estate.

Regulations Adoption with Antimicrobials Implementation

The numerous benefits of antimicrobial agents can be recognized across various sectors, including health treatments. Despite several advantages, inappropriate usage of antimicrobial agents within healthcare facilities can decisively lead to the acquisition of nosocomial infections, drug toxicity, unwanted resistance build-up, etc. The World Health Organization (WHO) has framed effective regulations on different quantities and combinations for using antimicrobial agents in pharmaceuticals. Fixed doses of antimicrobial combinations can be banned if not approved by national or international guidelines. Stringent legislation has been implemented functionally, regulating the antimicrobials prescribed by qualified healthcare professionals.

Several antimicrobial awareness campaigns, such as World Antibiotic Awareness Week held in November each year by the World Health Organization (WHO) and similar relevant campaigns, are frequently organized to address the benefits of antimicrobials and their consumption in the prescribed form.

Scientifically validated clinical studies have been provided with specific regulations to justify the choice and level of antimicrobial agents to be incorporated in health-related applications. Between November 2021 and February 2022, the regulatory entities and experts from international organizations conducted semi-structured interviews with scientists' regulators for India, Brazil, and South Africa to achieve and improve global and national perspectives on regulatory hurdles and evaluate innovation potential.

Antimicrobials Peptides Incorporated as Anticancer Agents Revolutionizing Healthcare Sector

Structurally described as small cationic or amphipathic molecules, antimicrobial peptides (AMPs) deliver an imperative fundamental defense against bacteria, viruses, and fungi. Several AMPs can target human cancer cells, specifically using their ability to bind the phospholipid phosphatidylserines (PS) that usually appear on the outer leaflet of plasma membranes. Recognized as a significant novel anticancer treatment, AMPs deliver a potential source of effective therapeutic agents and a primary defense against a broad spectrum of pathogens and harmful viruses.

According to the National Center for Health Statistics, the United States diagnosed approximately 1,918,030 cancer cases in 2022, where cancer rate in men was higher with 983,160 cases. Data published by Iqvia reported that the investment in 2022 on global cancer medicines was USD 196 billion, estimated to rise exponentially. The enormous potential for drug innovation in cancer treatment has incredibly generated huge opportunities for antimicrobial peptides globally.

Impact of COVID-19

The outbreak of COVID-19 had an unprecedented impact where the whole of mankind was vulnerable to the infectious disease. Due to the unavailability of significant antibiotics, antimicrobial resistance has successively threatened the entire healthcare system in treating untreatable bacterial infections. Some conventional practices, such as empirical antimicrobial prescription and excessive consumption of antimicrobial hygiene products, negatively impacted the prevalence of antimicrobial resistance. The pandemic significantly accentuated a bridge in sustainable funding across R&Ds of antimicrobial medicines and vaccine innovations. To address such challenges WHO and its partner Drugs for Neglected Diseases initiative (DNDi) progressively built the Global Antibiotic R&D Partnership (GARDP) to develop innovative and novel treatments. During the COVID-19 pandemic, the global market for antimicrobials was growing effectively which encouraged more companies to tackle the conflict of antimicrobial resistance.

Impact of Russia-Ukraine War

The invasion of Russia on Ukraine has led to economic as well as physical devastation that has impacted various sectors leading to instability in sequential investment. In March 2019, the Government of Ukraine has approved the National Action Plan to combat antimicrobial resistance protecting unjustified usage of antimicrobial compounds in applications like livestock, poultry, medicine, crop development, etc. The aggression of Russia has severely impacted Ukraine's healthcare system leading to increase of numerous bacterial infections among the injured soldiers. The medical aid from Western countries has stabilized the prevailing condition to a certain extent where such countries are regularly putting efforts to combat the war impact on the livelihood of Ukraine.

Key Players Landscape and Outlook

To deal with the antimicrobial resistance (AMR) that poses a serious threat to the healthcare systems in an unprecedented way, data reported that, due to hospital infections, an annual financial loss of around USD 13.5 billion occurred in the United States and the European Union. Bioversys is progressively working on innovations to fight antimicrobial resistance. It has prominently developed a diverse antimicrobial agent pipeline that specifically focuses on pathogens targeting gram-positive, gram-negative, and tuberculosis bacteria. Bioversys, on January 2023, has significantly extended the series C round to reach an investment of USD 35.07 million for AMR action, making its first European-based investment.

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on the Global Antimicrobials Market

4. Impact of Russia-Ukraine War

5. Executive Summary

6. Voice of Customer

6.1. Market Awareness and Product Information
6.2. Brand Awareness and Loyalty
6.3. Factors Considered in Purchase Decision
- 6.3.1. Brand Name
- 6.3.2. Quality
- 6.3.3. Quantity
- 6.3.4. Price
- 6.3.5. Product Specification
- 6.3.6. Application Specification
- 6.3.7. Shelf-life
- 6.3.8. Availability of Product
6.4. Frequency of Purchase
6.5. Medium of Purchase

7. Global Antimicrobials Market Outlook, 2016-2030F

7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.1.2. By Volume
7.2. By Grade
- 7.2.1. Food Grade
- 7.2.2. Pharma Grade
- 7.2.3. Industrial Grade
7.3. By Type
- 7.3.1. Organics
  - 7.3.1.1. Triclosan
  - 7.3.1.2. Quaternary Ammonium Compounds
  - 7.3.1.3. Others
- 7.3.2. Inorganics
  - 7.3.2.1. Copper
  - 7.3.2.2. Silver
  - 7.3.2.3. Zinc
  - 7.3.2.4. Others
7.4. By Applications
- 7.4.1. Antiviral Protection
- 7.4.2. Food Packaging
- 7.4.3. Bacterial Growth Inhibition
- 7.4.4. Others
7.5. By End-user
- 7.5.1. Homecare Essentials
- 7.5.2. Agriculture
- 7.5.3. Cleaners & Detergents
- 7.5.4. Paper & Pulp
- 7.5.5. Inks & Adhesives
- 7.5.6. Pharmaceuticals
- 7.5.7. Personal Care
- 7.5.8. Others
7.6. By Region
- 7.6.1. North America
- 7.6.2. Europe
- 7.6.3. South America
- 7.6.4. Asia-Pacific
- 7.6.5. Middle East and Africa
7.7. By Company Market Share (%), 2022

8. Global Antimicrobials Market Outlook, By Region, 2016-2030F

8.1. North America*
- 8.1.1. Market Size & Forecast
  - 8.1.1.1. By Value
  - 8.1.1.2. By Volume
- 8.1.2. By Grade
  - 8.1.2.1. Food Grade
  - 8.1.2.2. Pharma Grade
  - 8.1.2.3. Industrial Grade
- 8.1.3. By Type
  - 8.1.3.1. Organics
  - 8.1.3.1.1. Triclosan
  - 8.1.3.1.2. Quaternary Ammonium Compounds
  - 8.1.3.1.3. Others
  - 8.1.3.2. Inorganics
  - 8.1.3.2.1. Copper
  - 8.1.3.2.2. Silver
  - 8.1.3.2.3. Zinc
  - 8.1.3.2.4. Others
- 8.1.4. By Applications
  - 8.1.4.1. Antiviral Protection
  - 8.1.4.2. Food Packaging
  - 8.1.4.3. Bacterial Growth Inhibition
  - 8.1.4.4. Others
- 8.1.5. By End-user
  - 8.1.5.1. Homecare Essentials
  - 8.1.5.2. Agriculture
  - 8.1.5.3. Cleaners & Detergents
  - 8.1.5.4. Paper & Pulp
  - 8.1.5.5. Inks & Adhesives
  - 8.1.5.6. Pharmaceuticals
  - 8.1.5.7. Personal Care
  - 8.1.5.8. Others
- 8.1.6. United States*
  - 8.1.6.1. Market Size & Forecast
  - 8.1.6.1.1. By Value
  - 8.1.6.1.2. By Volume
  - 8.1.6.2. By Grade
  - 8.1.6.2.1. Food Grade
  - 8.1.6.2.2. Pharma Grade
  - 8.1.6.2.3. Industrial Grade
  - 8.1.6.3. By Type
  - 8.1.6.3.1. Organics
  - 8.1.6.3.1.1. Triclosan
  - 8.1.6.3.1.2. Quaternary Ammonium Compounds
  - 8.1.6.3.1.3. Others
  - 8.1.6.3.2. Inorganics
  - 8.1.6.3.2.1. Copper
  - 8.1.6.3.2.2. Silver
  - 8.1.6.3.2.3. Zinc
  - 8.1.6.3.2.4. Others
  - 8.1.6.4. By Applications
  - 8.1.6.4.1. Antiviral Protection
  - 8.1.6.4.2. Food Packaging
  - 8.1.6.4.3. Bacterial Growth Inhibition
  - 8.1.6.4.4. Others
  - 8.1.6.5. By End-user
  - 8.1.6.5.1. Homecare Essentials
  - 8.1.6.5.2. Agriculture
  - 8.1.6.5.3. Cleaners & Detergents
  - 8.1.6.5.4. Paper & Pulp
  - 8.1.6.5.5. Inks & Adhesives
  - 8.1.6.5.6. Pharmaceuticals
  - 8.1.6.5.7. Personal Care
  - 8.1.6.5.8. Others
- 8.1.7. Canada
- 8.1.8. Mexico

All segments will be provided for all regions and countries covered

8.2. Europe
- 8.2.1. Germany
- 8.2.2. France
- 8.2.3. Italy
- 8.2.4. United Kingdom
- 8.2.5. Russia
- 8.2.6. Netherlands
- 8.2.7. Spain
- 8.2.8. Turkey
- 8.2.9. Poland
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
8.4. Asia-Pacific
- 8.4.1. India
- 8.4.2. China
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. Vietnam
- 8.4.6. South Korea
- 8.4.7. Indonesia
- 8.4.8. Philippines
8.5. Middle East & Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. South Africa

9. Supply Side Analysis

9.1. Capacity, By Company
9.2. Production, By Company
9.3. Operating Efficiency, By Company
9.4. Key Plant Locations (Up to 25)

10. Market Mapping, 2022

10.1. By Grade
10.2. By Type
10.3. By Application
10.4. By End-user
10.5. By Region

11. Macro Environment and Industry Structure

11.1. Supply Demand Analysis
11.2. Import Export Analysis - Volume and Value
11.3. Supply/Value Chain Analysis
11.4. PESTEL Analysis
- 11.4.1. Political Factors
- 11.4.2. Economic System
- 11.4.3. Social Implications
- 11.4.4. Technological Advancements
- 11.4.5. Environmental Impacts
- 11.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
11.5. Porter's Five Forces Analysis
- 11.5.1. Supplier Power
- 11.5.2. Buyer Power
- 11.5.3. Substitution Threat
- 11.5.4. Threat from New Entrant
- 11.5.5. Competitive Rivalry

12. Market Dynamics

12.1. Growth Drivers
12.2. Growth Inhibitors (Challenges, Restraints)

13. Key Players Landscape

13.1. Competition Matrix of Top Five Market Leaders
13.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
13.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
13.4. SWOT Analysis (For Five Market Players)
13.5. Patent Analysis (If Applicable)

14. Pricing Analysis

15. Case Studies

16. Key Players Outlook

16.1. Iasis Molecular Science¬¬¬¬¬¬¬
- 16.1.1. Company Details
- 16.1.2. Key Management Personnel
- 16.1.3. Products & Services
- 16.1.4. Financials (As reported)
- 16.1.5. Key Market Focus & Geographical Presence
- 16.1.6. Recent Developments
16.2. EnBiotix Inc.
16.3. Armata Pharmaceuticals
16.4. GlaxoSmithKline
16.5. Fresenius Kabi Global
16.6. Destiny Pharma
16.7. Phico Therapeutics
16.8. SaNOtize
16.9. BioVersys
16.10. Pylum Biosciences

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

抗菌剤の世界市場の評価：グレード別、タイプ別、用途別、エンドユーザー別、地域別、機会、予測（2016年～2030年）

Antimicrobials Market Assessment, By Grade, By Type, By Applications, By End-user, By Region, Opportunities and Forecast, 2016-2030F

生活必需品への広範な用途が市場の成長を後押し

抗がん剤として組み込まれた抗菌ペプチドが医療部門に革命を起こす

COVID-19の影響

ロシア・ウクライナ戦争の影響

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 世界の抗菌剤市場に対するCOVID-19の影響

第4章 ロシア・ウクライナ戦争の影響

第5章 エグゼクティブサマリー

第6章 顧客の声

第7章 世界の抗菌剤市場の見通し（2016年～2030年）

第8章 世界の抗菌剤市場の見通し：地域別（2016年～2030年）

第9章 サプライサイド分析

第10章 市場マッピング（2022年）

第11章 マクロ環境と産業構造

第12章 市場力学

第13章 主要企業情勢

第14章 価格分析

第15章 ケーススタディ

第16章 主要企業の見通し

第17章 戦略的推奨事項

第18章 当社について、免責事項